Risk factors control in diabetes: The "real world" of clinical practice

Diabetes Educator

Volumn 34, Issue 5, 2008, Pages 763-764

  Escobar, Carlos ^a   Barrios, Vivencio ^b  

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ATHEROSCLEROSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CLINICAL TRIAL; DIABETES MELLITUS; DIABETIC ANGIOPATHY; HUMAN; LETTER; PRACTICE GUIDELINE; RISK FACTOR;

ADULT; ATHEROSCLEROSIS; CHOLESTEROL, LDL; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS; DIABETIC ANGIOPATHIES; HUMANS; PRACTICE GUIDELINES AS TOPIC; RISK FACTORS;

EID: 52349122782     PISSN: 01457217     EISSN: 15546063     Source Type: Journal    
DOI: 10.1177/0145721708325532     Document Type: Letter

References (6)

1. Gaede P., Vedel P., Larsen N., Jensen GV, Parving HH, Pedersen O. Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes. N Engl J Med. 2008 ; 358: 580-591.
2. Howard BV, Roman MJ, Devereux RB, et al. Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trial. JAMA. 2008 ; 299: 1678-1689.
3. Escobar C., Barrios V., Caldern A., et al. Diabetes mellitus in hypertensive population attended in primary care in Spain. Blood pressure and lipid control rates. Rev Clin Esp. 2007 ; 207: 221-227.
4. Vaccaro O., Boemi M., Cavalot F., et al. The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis. 2008 ; 198: 396-402.
5. Martin OJ, Wu WC, Taveira TH, Eaton CB, Sharma SC Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes: a pilot study. Diabetes Educ. 2007 ; 33: 118-127.
6. Steg PG, Lopez-Sendon J., Lopez de Sa E., et al. External validity of clinical trials in acute myocardial infarction. Arch Intern Med. 2007 ; 167: 68-73.